Stock Events

Stock Events

Glenmark Pharmaceuticals (GLENMARK.NSE) Q4 2024 Earnings

14NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-43.97

-24.38

-4.78

14.82

Details

Expected EPS

14.818410903450001

Actual EPS

12.651092301925

Surprise EPS

-2.17

Surprise Percent

+14.63%

Description

Glenmark Pharmaceuticals (GLENMARK.NSE) has reported earnings of 12.651092301925 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.